Find Academic Supervisors

Elisa De FrancoView profile

Research Fellow

• Genetics
• Neonatal Diabetes
• Pancreatic Development
• +5 more

Dr. Elisa De Franco is a Clinical and Biomedical Sciences researcher at the University of Exeter Medical School , affiliated with the NIHR Exeter Biomedical Research Centre. She has held prestigious fellowships including the Diabetes UK RD Lawrence Fellowship (2019-2024) and the EFSD/Novo Nordisk Future Leaders Fellowship (2023-2028). Elisa leads the neonatal diabetes genetic testing service at Diabetes Genes . Education: BSc (University of Turin, Italy, 2008) MSc (University of Turin, Italy, 2010) PhD (Peninsula College of Medicine & Dentistry, 2014) Research Focus: Elisa investigates genetic causes of neonatal diabetes, pancreatic development, and beta cell dysfunction. Her work integrates exome sequencing, whole genome sequencing, and bioinformatics to uncover novel disease mechanisms, with applications in type 1 diabetes research and cell-based therapies . Scientific Contributions: Her research has identified genes like PAX4, ZNF808, and FICD in neonatal diabetes etiology. She has published extensively in journals like Journal of Clinical Investigation and Diabetologia , with a focus on genotype-phenotype correlations , endoplasmic reticulum stress , and imprinting disorders . Awards: Diabetes UK RD Lawrence Fellowship (2019) EFSD/Novo Nordisk Future Leaders Fellowship (2023) Marie Curie BOLD Project Funding (PhD) Professional Activities: Elisa works part-time as a Healthcare Scientist in the NHS Exeter exome service (2017-2019) and leads international collaborations, including studies on genetic etiologies in Sudan, Vietnam, and Kurdistan. She is a key contributor to consensus reports on precision diabetes medicine.

Ashley JonesView profile

Research Fellow

• Plant Adaptation
• Climate Change Biology
• Fungal Pathogens
• +4 more

Dr. Ashley Jones is a Research Fellow at the Australian National University (ANU), affiliated with the Biology Teaching & Learning Centre and the Division of Plant Sciences. His research focuses on plant adaptation to environmental challenges, including climate change and fungal pathogens, leveraging long-read sequencing and bioinformatics. He holds a PhD in Plant Molecular Biology from ANU and a Bachelor of Biotechnology from the University of Newcastle, where he earned multiple academic awards. Jones has secured $866K in funding, including grants from DAFF, CSIRO, and industry partners like Forest & Wood Products Australia. His work bridges basic research with practical conservation outcomes through collaborations with government agencies and botanic gardens. He has also contributed to SARS-CoV-2 genomic surveillance during the pandemic, aiding public health decision-making. Education: PhD, Plant Molecular Biology (ANU, 2017) Bachelor of Biotechnology (University of Newcastle, Honours Class I with University Medal, 2011) Research Interests: Jones investigates adaptive mechanisms in Australian native plants, genomic responses to environmental stress, and host-pathogen interactions. His lab employs cutting-edge sequencing technologies to study genome structure, gene regulation, and evolutionary adaptation. Recent projects include sequencing the Eucalyptus regnans genome and analyzing fungal pathogens like Austropuccinia psidii. Awards: Alan Wilton Award (Genetics Society of Australasia) Education and Outreach Award (ASPS) Science Innovation Award (DAFF) Harry Medlin Science Award (University of Adelaide) Grants & Projects: Principal Investigator: $369K in grants, including a $22K DAFF award and a $60K John Stocker Award. Collaborative Grant: $497K Australia's Economic Accelerator Ignite Grant (team). Labs & Teams: Jones collaborates with CSIRO, ACT Health, and institutions like the University of Adelaide. His work integrates genomic tools with ecological and agricultural applications to address biodiversity conservation and crop resilience.

Victoria MellerView profile

Professor

• Genetics
• Epigenetics
• Gene Regulation
• +3 more

Victoria Meller is a Professor in the Department of Biological Sciences at Wayne State University's College of Liberal Arts and Sciences. Her research focuses on epigenetic regulation of gene expression, particularly dosage compensation mechanisms in Drosophila and mammals. She leads a lab investigating non-coding RNAs (e.g., roX RNAs) and their roles in chromatin modification. Education: Ph.D. in Biology from the University of North Carolina, Chapel Hill (1990). Research Interests: Genetics, epigenetics, gene regulation, and the functional roles of long/short non-coding RNAs in chromatin-based regulatory systems. Current projects explore regulatory networks underlying X chromosome modifications and the convergence of dosage compensation mechanisms between flies and mammals. Key Findings: Demonstrated redundancy of roX1/roX2 RNAs in Drosophila dosage compensation, identified roles for siRNA in X chromosome recognition, and discovered parallels between Drosophila and mammalian X-inactivation pathways. Awards: AAAS Fellow (2019), NIH and NSF grants, including NIH RO1 GM093110 and NSF 0641121. Teaching: Courses include Genetics (BIO3070), Eukaryotic Gene Structure (BIO7510), and Responsible Conduct of Research (BIO6700). Lab Activities: Active research on satellite repeats, chromatin architecture, and RNA-dependent regulatory pathways. Collaborations include genomic studies on mosquito X chromosome regulation and heterochromatin dynamics.

Daniel BauerView profile

Associate Professor

• Gene Therapy
• Genome Editing
• CRISPR-Cas9
• +14 more

Daniel Bauer is a faculty member at Boston Children's Hospital and Dana-Farber Cancer and Blood Disorders Center, affiliated with Harvard Medical School in the Department of Hematology and Oncology. His research is centered on developing gene-editing therapies for blood disorders, particularly sickle cell disease and thalassemia. University: Boston Children's Hospital School: Harvard Medical School Department: Department of Hematology and Oncology Dr. Bauer’s research focuses on leveraging CRISPR and base editing technologies to reactivate fetal hemoglobin and correct genetic defects in hematopoietic stem cells. His work spans from mechanistic studies of hemoglobin switching regulators like BCL11A to translational applications in non-human primates and human cells. He has pioneered methods to improve editing efficiency, reduce genotoxicity, and develop safer delivery systems. His recent publications highlight a strong trend in refining gene-editing tools for clinical use—emphasizing in vivo delivery, off-target assessment, prime editing optimization, and culture-free editing to preserve stem cell function. These studies demonstrate a clear trajectory toward curative therapies for hemoglobinopathies. Dr. Bauer has mentored trainees and led a productive research program, though specific student names and awards are not listed in the provided text. He has secured research funding to support his lab’s work in genome editing and therapeutic development. He leads a research team focused on genetic medicine for blood disorders, integrating molecular biology, genomics, and preclinical models to advance gene therapy. His lab is actively involved in both basic and translational research, aiming to bridge the gap between bench discoveries and clinical applications.

Geoff BurnsView profile

Researcher

• Developmental Biology
• Cardiovascular Development
• Molecular Cardiology
• +7 more

Geoff Burns is a researcher affiliated with the Cardiology Research unit at Boston Children's Hospital. His work focuses on the molecular and genetic mechanisms underlying cardiac development and regeneration, primarily using zebrafish as a model organism. He has contributed extensively to understanding heart morphogenesis, gene regulation, and the impact of environmental toxins on embryonic heart development. His research interests span developmental biology, molecular cardiology, and regenerative medicine. Key areas include Wnt and TGF-β signaling pathways, microRNA regulation (e.g., miR-143), ion channel function in heart development, and the role of extracellular matrix components in cardiac patterning. His studies often integrate genetic, biochemical, and physiological approaches in zebrafish embryos. The body of his published work reveals a strong focus on early cardiac development, with recurring themes in transcriptional regulation, cell signaling, and structural protein function. Many of his recent articles explore how mechanical and electrical signals influence heart formation and regeneration, highlighting a systems-level approach to developmental cardiology. While no formal awards are listed in the provided text, his publications in high-impact journals such as Nature , Cell , and PNAS reflect significant scientific contributions. His research has likely been supported by major grants in cardiovascular development and regeneration, though specific funding sources are not mentioned. Geoff Burns has not listed any advisees or students in the available information. However, given the depth and independence of his research output, he may have mentored trainees within the hospital’s research environment. He is part of a larger cardiovascular research team at Boston Children’s Hospital, which likely includes collaborators in genetics, physiology, and clinical cardiology.

• Epigenetics
• Chromatin Biology
• Histone Modifications
• +5 more

Erin Green is an Associate Professor in the Department of Biological Sciences at the University of Maryland, Baltimore County (UMBC), where she leads an active research laboratory investigating epigenetic regulation through protein post-translational modifications. Her work integrates molecular biology, genetics, biochemistry, genomics, and proteomics using Saccharomyces cerevisiae and mammalian models to study chromatin signaling pathways in gene expression and stress response. Education: Postdoctoral Fellowship, Stanford University (2013) Ph.D., University of California, Berkeley (2007) B.A., Bryn Mawr College (2000) Dr. Green's research focuses on how histone methylation, particularly at lysine residues, regulates chromatin structure and function to maintain genomic integrity during cellular stress and gene expression. Her lab investigates canonical and novel methylation sites, non-histone protein methylation, and the role of lysine methyltransferases like Set5 and SMYD proteins in telomere maintenance and cancer pathways. Using evolutionary conserved yeast models, her work provides insights into human diseases including tumorigenesis and aging-related pathologies. Analysis of her 15 most recent publications reveals consistent emphasis on chromatin stress responses, telomere biology, and lysine methylation signaling. Key trends include: (1) mechanistic studies of SET domain proteins in stress adaptation, (2) crosstalk between histone modifications and DNA repair, (3) translational implications for cancer metastasis (particularly prostate cancer via SMYD3-MAP3K2 axis), and (4) development of yeast models for human aging processes. Her work bridges fundamental chromatin biology with disease mechanisms through conserved epigenetic pathways. Dr. Green has secured significant research funding including multiple NIH grants: a funded R01 on lysine methylation in chromatin and stress responses (2017-2022), an active project on SMYD lysine methyltransferase Set6 (2023-present), and previously funded work on telomere chromatin homeostasis (2016). She actively mentors graduate students including recent PhD graduates (Maraki Negesse, Elgar Gabibov) and current candidates (Chase Andre, Fidelia Asomani), with several trainees presenting at national conferences and publishing high-impact work. The Green Lab maintains a dynamic research environment within UMBC's Biological Sciences Building, characterized by frequent conference presentations (ASBMB, FASEB), collaborative projects, and integration of undergraduate researchers through programs like Meyerhoff and U-RISE. Current work focuses on lysine methylation signaling in stress responses, with ongoing projects examining noncanonical SET domain functions and SMYD methyltransferase roles in proteostasis.

Brankica MravinacView profile

Researcher

• Molecular Biology
• Genetics
• Evolutionary Biology
• +3 more

Brankica Mravinac is a Senior Research Associate at the Ruđer Bošković Institute in Zagreb, Croatia, affiliated with the Division of Molecular Biology and Laboratory of Non-Coding DNA. Her research focuses on satellite DNA evolution, centromere structure, and epigenetic regulation in insects and nematodes. Ph.D., University of Zagreb, Faculty of Science (2004) M.Sc., University of Zagreb, Faculty of Science (2000) B.Sc., University of Zagreb, Faculty of Science (1996) Her work spans evolutionary genetics, genomic organization, and functional analysis of repetitive DNA sequences, particularly in Tribolium beetles and Meloidogyne nematodes. Current projects include high-throughput satellitome analyses and (epi)genomic studies during embryogenesis. Recent publications highlight satellite DNA propagation mechanisms, centromere epigenetics, and transposable element interactions. She has mentored students in satellite DNA characterization, nematode centromere studies, and molecular marker development. Annual Award of the Ruđer Bošković Institute for best scientific papers (2020, 2010) She teaches a doctoral course on non-coding DNA and contributes to methodological training at the Ruđer Bošković Institute. Her research involves collaborations with Croatian Science Foundation and Adris Foundation projects.

Beryl JonesView profile

Assistant Professor

• Genomics
• Socio-behavioral plasticity
• Social insects
• +5 more

Beryl Jones is an Assistant Professor in the Department of Entomology at the University of Kentucky's Martin-Gatton College of Agriculture, Food and Environment. Her research focuses on the genomics of socio-behavioral plasticity in wild bees, integrating behavior, ecology, and modern computational biology approaches to understand phenotypic complexity evolution. She serves as both a Career and Professional Mentor and Research Mentor for students. Dr. Jones received her educational training through: B.S. in Ecology and Evolutionary Biology, Biochemistry, University of Arizona, 2011 Ph.D. in Ecology, Evolution, and Conservation Biology, University of Illinois at Urbana-Champaign, 2019 Her research program centers on social insects as models for evolutionary transitions and phenotypic plasticity. The Jones Lab specifically studies sweat bees (Halictidae) which exhibit remarkable plasticity within and across species, repeated gains and losses of social traits, and newly developed genomic resources. Her work integrates behavioral ecology with computational biology and genomics to understand the mechanisms behind phenotypic complexity. This research has implications for understanding evolutionary transitions, social behavior development, and the genetic basis of plasticity across developmental and evolutionary timescales. Analysis of Dr. Jones' publication record reveals a consistent focus on the genomics of social behavior in bees, with particular attention to sweat bees as model organisms. Her work spans molecular, physiological, and behavioral levels, connecting gene regulatory networks to social phenotypes. Recent research has increasingly incorporated advanced computational methods including AI and machine learning for behavioral tracking. Her publications span high-impact journals across evolutionary biology, genomics, and entomology, reflecting the interdisciplinary nature of her work. Dr. Jones has received numerous scientific awards throughout her career: George C. Eickwort Student Research Award (IUSSI-NAS) 2019 Robert Emerson Memorial Award (UIUC) 2018 NSF Graduate Research Fellowship 2012-2015 Illinois Distinguished Fellowship 2012-2018 Multiple undergraduate research awards including the Barry M. Goldwater Fellowship Dr. Jones actively mentors students and has served as a Teaching Assistant, Guest Lecturer, and Lecturer for various courses including Bioinformatics and Bees and Beekeeping. She is currently recruiting M.S. and Ph.D. students for her lab. Her research has been supported by multiple grants including NSF funding and institutional fellowships. Dr. Jones has also served on graduate admissions committees, organized conferences, and participated in peer review for numerous journals. The Jones Lab focuses on the genomics of socio-behavioral plasticity in wild bees, particularly sweat bees in the family Halictidae. The lab integrates behavioral ecology with computational biology and genomics to understand the evolution and development of phenotypic complexity. Current research examines how social traits evolve and are maintained through genetic and environmental interactions, with particular attention to facultatively eusocial species that can switch between solitary and social behaviors.

Hannah LongView profile

Research Professor

• Gene Regulation
• Craniofacial Development
• Enhancer Function
• +7 more

Dr. Hannah Long is a Programme Leader at the MRC Human Genetics Unit within the Institute of Genetics and Cancer at the University of Edinburgh. Her research focuses on understanding gene regulation mechanisms in human craniofacial development and disease. She leads an active research group investigating how enhancers and non-coding DNA elements control gene expression during embryonic development, with particular emphasis on craniofacial disorders and congenital conditions. Dr. Long's research centers on the role of enhancers and chromatin structure in craniofacial development. Her lab utilizes human embryonic stem cells differentiated into cranial neural crest cells (CNCCs), animal models, genome-editing, epigenomic analysis, and imaging approaches. Key research areas include understanding how clusters of enhancers regulate gene expression, exploring local 3D topology and gene regulation, and investigating how chromosomal structure relates to gene activity. Her work has significant implications for understanding human congenital disorders. Analysis of Dr. Long's publication record reveals a consistent focus on enhancer biology and gene regulation in development. Her work spans from fundamental mechanisms of enhancer function to their role in human disease, with particular emphasis on long-range regulatory interactions involving the SOX9 gene. She frequently publishes in high-impact journals including Cell, Molecular Cell, and Cell Stem Cell, demonstrating the significance of her contributions to understanding how non-coding genetic elements control development and cause disease. Dr. Long actively mentors the next generation of scientists, supervising PhD students and postdoctoral researchers including Verena Obermuller, Ewa Ozga, and Kasia Milto. Her research is supported by the Medical Research Council (MRC), reflecting the importance of her work in understanding the genetic basis of craniofacial development and disorders. Dr. Long leads a dynamic research group within the MRC Human Genetics Unit at the University of Edinburgh, comprising postdoctoral scientists, research assistants, and PhD students. The lab maintains collaborations with researchers at Stanford University, University of Edinburgh, KU Leuven, and other institutions, creating a vibrant interdisciplinary research environment focused on understanding the fundamental mechanisms of gene regulation during development.

Qi ChengView profile

Professor

• Theoretical Computer Science
• Cryptography
• Computational Number Theory
• +3 more

Qi Cheng is the Williams Company Foundation Presidential Professor of Computer Science at the University of Oklahoma, where he has been since 2001. His academic roles include leadership in theoretical computer science research and teaching. Education: Ph.D., Computer Science, University of Southern California (2001) M.S., Computer Science, Fudan University (1995) B.S., Computer Science, Nankai University (1992) Research Interests: Focuses on theoretical computer science, cryptography, computational number theory, DNA/molecular computing, and coding theory. His work explores algorithmic self-assembly, lattice-based cryptography, and polynomial system solving over finite fields. Key Contributions: Includes advancements in self-assembly theory, decoding algorithms for Reed-Solomon codes, and complexity analyses of algebraic problems. His NSF CAREER project integrated self-assembly research with educational initiatives. Grants & Awards: Recipient of the NSF Career Award (2003–2008) for self-assembly research, and multiple NSF grants (e.g., CCF-1900820, CCF-1409294) supporting work on sparse polynomials and algebraic codes. Labs/Teams: Leads research groups focused on theoretical computer science and cryptography, collaborating on projects involving post-quantum cryptography and algorithmic number theory.

Nancy JohnsonView profile

Assistant Clinical Professor

• Women's Health
• Sexual Assault
• Inner City Healthcare
• +2 more

Nancy Johnson serves as a Clinical Assistant Professor and Medical Director of the SART (Sexual Assault Response Team) Program in the Department of Emergency Medicine at SUNY Downstate Medical Center. She completed her medical education in 2003 and completed her residency training at Kings County Hospital Center/SUNY Downstate. Dr. Johnson's research interests span Women's Health, Sexual Assault medicine, and Inner City Healthcare. Her work addresses critical issues in emergency medicine with a focus on vulnerable populations, particularly in urban settings. She has published on topics ranging from violence-related injuries in inner city populations to women's health issues, demonstrating her commitment to addressing health disparities. Analysis of her publication record shows significant contributions across multiple medical disciplines including emergency medicine, women's health, infectious diseases, and gastroenterology. Her recent work includes publications on gastric organoid modeling (2024), tick-borne encephalitis (2023), surgical approaches to hysterectomy (2023), and fertility preservation for transgender men (2022), indicating a broad research portfolio that extends beyond emergency medicine into women's health and related fields. Dr. Johnson has contributed to high-impact journals including Molecular Cell, Fertility and Sterility, and the Cochrane Database of Systematic Reviews. Her research demonstrates interdisciplinary collaboration across medical specialties. As Medical Director of the SART Program, Dr. Johnson oversees clinical services related to sexual assault response, combining her academic role with direct patient care and program leadership in this specialized area of emergency medicine.

• Molecular Genetics
• Ophthalmology
• Corneal Diseases
• +5 more

Alice Davidson serves as Associate Professor of Molecular Genetics at University College London's Institute of Ophthalmology, holding a UKRI Future Leaders Fellowship (2020-2027) and serving as Deputy Chair of the Ophthalmology Basic & Applied Science Interim Exam Board. Her research program focuses on inherited corneal diseases with emphasis on Fuchs endothelial corneal dystrophy (FECD), supported by £3.5 million in research funding since 2015. Her educational background includes a PhD in Molecular Genetics and Cell Biology (2010) and BSc (2006), both from the University of Manchester. She completed postdoctoral training at UCL Institute of Ophthalmology investigating genetic causes of retinal and corneal diseases. Davidson's research integrates molecular genetics, bioinformatics, and cellular models to elucidate disease mechanisms in corneal disorders. Her work establishes international leadership in FECD research through development of patient-derived cellular systems and interdisciplinary collaborations spanning academic, clinical, and industrial partners. Current projects address triplet repeat expansion disorders with implications for neurological conditions. Recent publications demonstrate strong output in corneal genetics, with 2024-2025 articles focusing on AI applications for FECD diagnosis, TCF4 repeat expansion mechanisms, and novel gene discoveries for corneal dystrophies. Her work shows consistent translational impact through development of diagnostic frameworks and therapeutic approaches. UKRI Future Leaders Fellowship (2020-2024, renewed 2024-2027) Fight for Sight Early Career Investigator Award (2015) Davidson actively supervises PhD students, having successfully guided two to completion and currently mentoring three primary supervisees plus secondary students. Her leadership extends to directing UCL's corneal disease bio-resource and cellular model systems. Current research emphasizes gene-directed therapeutic strategies with potential applications across multiple repeat expansion disorders.

• Endocrine toxicology
• Endocrine-disrupting chemicals
• Molecular pathways regulating energy metabolism
• +10 more

Dr. Jorke Kamstra is an Associate Professor at the Division of Toxicology, Institute for Risk Assessment Sciences (IRAS), Faculty of Veterinary Medicine, Utrecht University, where he leads the endocrine toxicology team. His research focuses on understanding how endocrine-disrupting chemicals (EDCs) interfere with molecular pathways regulating energy metabolism and cellular differentiation, particularly in metabolic diseases such as obesity and type 2 diabetes. Dr. Kamstra received his PhD from the Norwegian University of Life Sciences (NMBU) in 2017, where he studied transgenerational effects of environmental stress via epigenetic inheritance in zebrafish. Before his PhD, he worked for over a decade as a research technician at the Institute for Environmental Studies, Vrije Universiteit Amsterdam. In 2014, he earned his MSc in Molecular Cell Biology cum laude. His research centers on how metabolic disruptors act on transcriptional and epigenetic regulatory networks, influencing gene expression programs and shaping phenotypes. He is particularly interested in epigenetic reprogramming's role in mediating persistent or transgenerational effects of EDCs. His team combines mechanistic toxicology with systems-level approaches to uncover critical pathways underlying EDC-induced metabolic dysfunction. They develop and apply in vitro models or new approach methodologies (NAMs) to study effects on adipocyte, liver, and pancreas to identify chemical stressors with metabolism-disrupting potential. Current research topics include EDC effects on fatty liver disease (EDC-MASLD), BPA alternatives' effects on adiposity via PPAR gamma (PARC), and PFAS effects on adipogenesis and pancreas (AFARA). Analysis of Dr. Kamstra's publication record reveals a strong focus on epigenetic mechanisms of endocrine disruption, transgenerational effects, and metabolism-disrupting chemicals. His work spans from fundamental molecular mechanisms to applied risk assessment, with increasing emphasis on developing standardized in vitro models for regulatory purposes. Recent publications show growing interest in microplastics and nanoplastics effects on reproduction and early development. Dr. Kamstra has published extensively in high-impact journals, with his work cited widely in the fields of toxicology, epigenetics, and environmental health. His research has contributed significantly to understanding how environmental chemicals disrupt metabolic pathways through epigenetic mechanisms. He is actively involved in teaching courses including Advanced Toxicology and Health Effects Toxicology - Food, Pesticides and Drugs. His team includes PhD students and postdoctoral researchers working on various aspects of endocrine and metabolic disruption, contributing to the development of innovative, animal-free approaches for chemical safety assessment.

Christopher LoweView profile

Professor

• Evolutionary Developmental Biology
• Deuterostome Evolution
• Comparative Genomics
• +4 more

Christopher Lowe is a Professor of Biology at Stanford University, with his research laboratory based at the Hopkins Marine Station in Monterey. He holds additional appointments as a Member of Bio-X and the Wu Tsai Neurosciences Institute, and serves as Director of the Center of Cellular and molecular Diversity (2022-Present). His academic journey began with a BSc. Hons in Biology with European Studies from the University of Sussex (1991), followed by a PhD in Ecology and Evolution from SUNY Stony Brook (1998). University of Sussex: BSc. Hons, Biology with European Studies (1991) SUNY Stony Brook: PhD, Ecology and Evolution (1998) UC Berkeley: Miller Fellow (1998-2001) University of Chicago: Assistant Professor, Department of Organismal Biology and Anatomy (2005) Stanford University: Professor of Biology (2010-Present) Professor Lowe's primary research focuses on evolutionary developmental biology, specifically investigating how major animal groups evolved through the lens of deuterostome evolution. His work integrates molecular genetics, comparative genomics, and developmental biology to understand body plan evolution, particularly using hemichordates as model organisms. He has pioneered techniques for studying non-model marine organisms and has adapted emerging biotechnologies for application in diverse species. His location at Hopkins Marine Station provides unique access to the rich biodiversity of Monterey Bay, which informs his research on marine invertebrate development and evolution. Analysis of Professor Lowe's recent publications reveals a consistent focus on deuterostome evolution, with particular emphasis on hemichordates as key organisms for understanding chordate origins. His work spans multiple disciplines including developmental genetics, comparative genomics, neuroanatomy, and evolutionary immunology. A notable trend is the integration of cutting-edge molecular techniques with classical comparative morphology to address fundamental questions about body plan evolution. His research has significantly contributed to understanding anteroposterior patterning, nervous system organization, and the molecular basis of morphological innovation across deuterostomes. BioHub Investigator, Chan/Zuckerberg BioHub (2022-2027) Searle Scholars Fellow, Searle Scholars Program (2008-2011) Miller Postdoctoral Fellowship, UC Berkeley (1998-2001) Professor Lowe actively mentors the next generation of scientists, serving as Doctoral Dissertation Advisor for multiple PhD students including Christopher Kirby, Lauren Lubeck, Albert Marti i Sabari, Brennan McDonald, and Heidi Tate. He also sponsors postdoctoral researchers such as Laurent Formery and Jana Sipkova, and serves as a Doctoral Dissertation Reader for Joel Erberich. His laboratory at Hopkins Marine Station functions as a hub for evolutionary developmental biology research, focusing on comparative studies of deuterostome development. The lab has developed innovative techniques for studying non-model marine organisms, including transgenic methods for hemichordates and tissue clearing protocols for opaque invertebrates. Professor Lowe's research group collaborates extensively with other institutions to advance our understanding of evolutionary processes that shaped animal diversity.

• Medical Genomics
• Epigenetics
• Stem Cell Differentiation
• +3 more

John M. Greally is a Professor in the Department of Genetics and Pediatrics at Albert Einstein College of Medicine, serving as Chief of the Division of Genomics and Director of the Center for Epigenomics. He holds the Gottesman Faculty Scholar for Epigenomics title and advises key facilities like the Computational Genomics Core. His research focuses on medical genomics and epigenetics, particularly in understanding genetic and environmental influences on stem cell differentiation and rare diseases. He leads initiatives to advance genomic diagnostics through long-read sequencing and founded Latent Genomics, a startup applying medical genomics in clinical care. Education: MB, BCh, BAO (National University of Ireland, 1988); PhD (2016), DMed (2016) His research integrates genomic technologies, advanced data analysis, and stem cell systems to study non-coding genome variants and cellular memory mechanisms. Clinical efforts emphasize equitable genomic services for diverse populations through the New York Center for Rare Diseases. Key honors include the Mentor of the Year in Basic Science (2014) and Fellowship in the American College of Medical Genetics and Genomics. He contributes editorially to Epigenetics and Chromatin and PLOS Genetics , and holds a patent for cytosine methylation detection methods. Professional affiliations include the American Society of Human Genetics and leadership roles such as President of the New York Celtic Medical Society (2021-2023). His work spans basic research, clinical diagnostics, and translational medicine, with over 60 peer-reviewed publications and international presentations.